GENEFORM TECHNOLOGIES LIMITED
LONDON

Hellopages » City of London » City of London » EC4M 7RD

Company number 04549240
Status Active
Incorporation Date 1 October 2002
Company Type Private Limited Company
Address ORION PHARMA (UK) LIMITED, 5 FLEET PLACE, LONDON, ENGLAND, EC4M 7RD
Home Country United Kingdom
Nature of Business 72190 - Other research and experimental development on natural sciences and engineering
Phone, email, etc

Since the company registration sixty-four events have happened. The last three records are Confirmation statement made on 1 October 2016 with updates; Registered office address changed from C/O Orion Pharma (Uk) Limited 5 Fleet Place London England EC4M 7rd to C/O Orion Pharma (Uk) Limited 5 Fleet Place London EC4M 7rd on 3 October 2016; Full accounts made up to 30 September 2015. The most likely internet sites of GENEFORM TECHNOLOGIES LIMITED are www.geneformtechnologies.co.uk, and www.geneform-technologies.co.uk. The predicted number of employees is 1 to 10. The company’s age is twenty-three years and two months. The distance to to Brondesbury Park Rail Station is 4.9 miles; to Barnes Bridge Rail Station is 7 miles; to Beckenham Hill Rail Station is 7.3 miles; to Bickley Rail Station is 10.2 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Geneform Technologies Limited is a Private Limited Company. The company registration number is 04549240. Geneform Technologies Limited has been working since 01 October 2002. The present status of the company is Active. The registered address of Geneform Technologies Limited is Orion Pharma Uk Limited 5 Fleet Place London England Ec4m 7rd. . KEMPPAINEN, Mikko Tapani is a Director of the company. SEPPANEN, Marko Juhani Tapio is a Director of the company. TARKKANEN, Kaisa is a Director of the company. Secretary ANANDAPPA, Francis Denzil Nihal has been resigned. Nominee Secretary BRIGHTON SECRETARY LTD has been resigned. Secretary SOMERFIELD CONSULTANTS LTD has been resigned. Director HOSER, Mark Jay, Dr has been resigned. Director KARAS, David Matthew has been resigned. Director RISSANEN, Jaakko Sakari has been resigned. Director SINCLAIR, Michael Jeffrey, Dr has been resigned. Nominee Director BRIGHTON DIRECTOR LTD has been resigned. The company operates in "Other research and experimental development on natural sciences and engineering".


Current Directors

Director
KEMPPAINEN, Mikko Tapani
Appointed Date: 08 August 2011
53 years old

Director
SEPPANEN, Marko Juhani Tapio
Appointed Date: 08 August 2011
56 years old

Director
TARKKANEN, Kaisa
Appointed Date: 01 October 2015
57 years old

Resigned Directors

Secretary
ANANDAPPA, Francis Denzil Nihal
Resigned: 31 December 2005
Appointed Date: 01 October 2002

Nominee Secretary
BRIGHTON SECRETARY LTD
Resigned: 07 October 2002
Appointed Date: 01 October 2002

Secretary
SOMERFIELD CONSULTANTS LTD
Resigned: 01 August 2011
Appointed Date: 18 August 2006

Director
HOSER, Mark Jay, Dr
Resigned: 01 August 2011
Appointed Date: 01 October 2002
66 years old

Director
KARAS, David Matthew
Resigned: 01 August 2011
Appointed Date: 07 September 2009
61 years old

Director
RISSANEN, Jaakko Sakari
Resigned: 01 October 2015
Appointed Date: 01 August 2011
65 years old

Director
SINCLAIR, Michael Jeffrey, Dr
Resigned: 15 October 2010
Appointed Date: 14 September 2009
82 years old

Nominee Director
BRIGHTON DIRECTOR LTD
Resigned: 07 October 2002
Appointed Date: 01 October 2002

Persons With Significant Control

Orion Pharma Uk Limited
Notified on: 6 April 2016
Nature of control: Ownership of shares – 75% or more

GENEFORM TECHNOLOGIES LIMITED Events

13 Dec 2016
Confirmation statement made on 1 October 2016 with updates
03 Oct 2016
Registered office address changed from C/O Orion Pharma (Uk) Limited 5 Fleet Place London England EC4M 7rd to C/O Orion Pharma (Uk) Limited 5 Fleet Place London EC4M 7rd on 3 October 2016
04 Jul 2016
Full accounts made up to 30 September 2015
02 Jan 2016
Compulsory strike-off action has been discontinued
30 Dec 2015
Annual return made up to 1 October 2015 with full list of shareholders
Statement of capital on 2015-12-30
  • GBP 13,330

...
... and 54 more events
02 Jan 2003
New secretary appointed
02 Jan 2003
New director appointed
07 Oct 2002
Secretary resigned
07 Oct 2002
Director resigned
01 Oct 2002
Incorporation